Invivyd
A senior role in drug substance process development for biologics, focusing on downstream purification and integration with GMP manufacturing operations. The role involves technical leadership, process scale-up, technology transfer, and collaboration with external manufacturing partners.
Headquarters
New Haven, Connecticut, United States
Company Size
51-200 employees
Founded
2020
Invivyd is a biotechnology company focused on developing antibody-based therapies to address evolving viral threats. Its mission is to rapidly and continually deliver antibody treatments that keep pace with viral evolution using platform-driven discovery, optimization, and deployment. Invivyd builds a responsive pipeline and manufacturing approach to enable fast updates and distribution as new variants emerge. The company positions its work to strengthen public-health preparedness by providing adaptable therapeutic options.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Invivyd.
29% above the average for this role
Invivyd appoints Michael Mina as chief medical officer
3 days ago
Senior Scientist, Viral Vector Process Development, Downstream
AstraZeneca
Director, CMC Product Development – Biologics
Beeline Medicines
Senior Research Engineer
Leica Biosystems
Analyst / Senior Analyst, Development Services (Purification)
Lonza
Scientist, Downstream Process Development
avidbio
Scientist I/II, DevOps Drug Substance
Digital Biology